Kezar Life Sciences buy William Blair
Start price
28.02.25
/
50%
€0.69
Target price
28.02.26
-
Performance (%)
-
End price
01.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kezar Life Sciences | - | - | - |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by William_Blair for this prediction
In the thread Kezar Life Sciences diskutieren
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for KZR provided by MarketBeat
In the thread Trading Kezar Life Sciences
Die von William_Blair gewählte maximale Laufzeit wurde überschritten

